Microbiome Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
11
NCT05354102
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
Phase: Phase 1
Role: Lead Sponsor
Start: May 1, 2022
Completion: Nov 30, 2025
Loading map...